News

Meitheal Pharmaceuticals Announces FDA Approval of Enoxaparin Sodium Injection, USP in the United States 

Meitheal Pharmaceuticals Announces Completion of Majority Stake Investment from Nanjing King-Friend Biochemical Pharmaceutical Company

Meitheal Pharmaceuticals Announces Launch of Heparin Sodium Injection, USP in the United States 

Meitheal Pharmaceuticals Announces Investment from Nanjing King-friend Biochemical Pharmaceutical Company for Majority Stake